Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
180 Life Sciences Corp. (ATNF) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-14.18M |
|
-- |
|
-- |
|
$6.32M |
|
$-6.32M |
|
$-0.14M |
|
$-6.46M |
|
$-6.46M |
|
$-6.17M |
|
$-6.17M |
|
$-6.17M |
|
$-6.17M |
|
$-6.32M |
|
$-5.96M |
|
0.92M |
|
0.92M |
|
$-15.49 |
|
$-15.49 |
|
| Balance Sheet Financials | |
$5.14M |
|
-- |
|
$7.62M |
|
$12.76M |
|
$3.50M |
|
$0.01M |
|
$0.01M |
|
$3.51M |
|
$9.25M |
|
$1.63M |
|
$9.25M |
|
3.18M |
|
| Cash Flow Statement Financials | |
$-1.48M |
|
-- |
|
$4.04M |
|
$1.98M |
|
$4.59M |
|
$2.61M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.47 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-66.67% |
|
-378.45% |
|
-48.33% |
|
-66.62% |
|
$2.91 |
|
$-1.62 |
|
$-1.62 |
|